Active Substance & Generic Molecule Directory
Glucose Monohydrate in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Glucose Monohydrate registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
8
Registered Brands
Availability in Malaysia:8 Prescription (MAL-A)
Showing 8 of 8 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL25076021AZ | B. Braun 0.15% Potassium Chloride & 5% Glucose Intravenous Infusion | 27.5 gm 500 ml | Prescription (MAL-A) | B. BRAUN MEDICAL INDUSTRIES SDN. BHD. | Compare → |
| MAL19986521AZ | B. BRAUN 0.3% SODIUM CHLORIDE & 3.3% GLUCOSE IV INFUSION BP (1000ML) | 3.63G | Prescription (MAL-A) | B. BRAUN MEDICAL INDUSTRIES SDN. BHD. | Compare → |
| MAL16105019AZ | CAPD/DPCA 17 Stay Safe Link Solution for Peritoneal Dialysis | 16.5 gm 1L | Prescription (MAL-A) | FRESENIUS MEDICAL CARE MALAYSIA SDN. BHD. | Compare → |
| MAL16105017AZ | CAPD/DPCA 18 Stay Safe Link Solution for Peritoneal Dialysis | 46.75gm 1L | Prescription (MAL-A) | FRESENIUS MEDICAL CARE MALAYSIA SDN. BHD. | Compare → |
| MAL16105022AZ | CAPD/DPCA 19 Stay Safe Link Solution for Peritoneal Dialysis | 25.0gm 1L | Prescription (MAL-A) | FRESENIUS MEDICAL CARE MALAYSIA SDN. BHD. | Compare → |
| MAL06091412AZ | CAPD/DPCA 19 STAY SAFE PERITONEAL DIALYSIS SOLUTION | 25.0 g 1000 ml | Prescription (MAL-A) | FRESENIUS MEDICAL CARE MALAYSIA SDN. BHD. | Compare → |
| MAL16105024AZ | CAPD/DPCA 3 Stay Safe Link Solution for Peritoneal Dialysis | 46.75gm 1L | Prescription (MAL-A) | FRESENIUS MEDICAL CARE MALAYSIA SDN. BHD. | Compare → |
| MAL16105025AZ | CAPD/DPCA 4 Stay Safe Link Solution for Peritoneal Dialysis | 25.0gm 1L | Prescription (MAL-A) | FRESENIUS MEDICAL CARE MALAYSIA SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.